Location History:
- Provincia de Buenos Aires, AR (2001)
- Prov. de Buenos Aires, AR (2006)
- Florida, AR (2006 - 2009)
Company Filing History:
3 out of 156 
1 out of 40 Years Active: 2001-2009
Title: Gerardo Burton: Innovator in Antiglucocorticoid Research
Introduction
Gerardo Burton is a notable inventor based in Florida, AR, recognized for his contributions to the field of pharmacology. He holds a total of 4 patents, focusing primarily on novel treatments for conditions associated with excess glucocorticoids.
Latest Patents
One of his latest patents is titled "Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) for treating excess of glucocorticoids." This invention relates to novel 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) analogues, which are used as antiglucocorticoids for the treatment and/or prophylaxis of diseases associated with an excess of glucocorticoids. In particular, it addresses conditions such as Cushing's syndrome, iatrogenic hypercortisolism, and depression. Additionally, he has developed a method for the preparation of 21-hydroxy-6,19-oxidoprogesterone (21OH-6OP) and its various derivatives, which also serve as antiglucocorticoids.
Career Highlights
Throughout his career, Gerardo Burton has worked with several prominent companies, including Applied Research Systems and Laboratoires Serono. His work has significantly impacted the development of treatments for glucocorticoid-related disorders.
Collaborations
He has collaborated with notable professionals in his field, including Carlos P. Lantos and Adriana Silvia Veleiro. Their combined expertise has contributed to the advancement of research in pharmacological treatments.
Conclusion
Gerardo Burton's innovative work in the development of antiglucocorticoids showcases his commitment to addressing critical health issues. His patents and collaborations reflect a significant contribution to medical science and the treatment of glucocorticoid excess.